Skip to main content

Closed

GILD: Gilead Sciences, Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+6.0% / yr

Operating margin38.3%

ROIC20.3%

Financially safe

Strong

Debt / equity0.94×

Interest coverage11.3×

Current ratio1.97×

Valuation

Unrated

P/E ratio17.5×

Dividend yield2.5%

Gilead Sciences, Inc.

GILDNASDAQ Global Select·USD·Closed

Gilead Sciences, Inc.

GILDNASDAQ·USD·Closed

$130.21

−0.82%

$130.21

−$1.07 (0.82%)

52W Range

45thpctl

Volume

0.80×avg

Mkt Cap

161.66BUSD

P/E

17.5TTM

Div Yield

2.47%ann

52W Range

45thpctl

Volume

0.80×avg

Market Cap

161.66BUSD

P/E Ratio

17.5TTM

Div Yield

2.47%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings